Walleye Trading LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2021$310,000
-42.6%
101,947
+65.2%
0.00%
-75.0%
Q4 2019$540,000
+241.8%
61,711
+320.4%
0.00%
+300.0%
Q3 2019$158,000
-72.4%
14,678
-67.5%
0.00%
-80.0%
Q2 2019$573,000
+59.2%
45,100
+384.9%
0.01%
+150.0%
Q1 2019$360,000
+16.5%
9,300
-38.8%
0.00%0.0%
Q4 2018$309,000
-20.6%
15,199
+79.1%
0.00%
+100.0%
Q3 2018$389,000
+872.5%
8,486
+1314.3%
0.00%
Q3 2016$40,0006000.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2019
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$20,706,0006.01%
Redmile Group, LLC 230,673$23,882,0002.95%
WEATHERBIE CAPITAL, LLC 241,419$24,994,0002.31%
Tekla Capital Management LLC 185,820$19,238,0002.02%
Ghost Tree Capital, LLC 25,000$2,588,0001.59%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$588,741,0001.56%
Iguana Healthcare Management, LLC 25,000$2,588,0001.48%
Eventide Asset Management 42,100$4,359,0001.34%
Bain Capital Public Equity Management, LLC 401,330$41,550,0001.17%
Rock Springs Capital Management LP 31,500$3,261,0001.16%
View complete list of PUMA BIOTECHNOLOGY INC shareholders